Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03797924 · ClinicalTrials.gov registry record · Early Phase 1
Intercostobrachial Nerve Block (ICBN) for Tourniquet Pain: Is it Necessary?
A Early Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 46
- Enrollment target
NCT03797924 is a Early Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 46 participants.
The verdict
NCT03797924, a Early Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
In this study the investigators would like to show that when patients undergo upper limb surgery under supraclavicular brachial plexus block, additional blocking of the Intercostobrachial Nerve Block (ICBN) does not affect the incidence or course of tourniquet pain.
Interventions
- DRUG Receive ICBN with ropivacaine
- BEHAVIORAL No ICBN block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2019-04-25 |
| Est. Completion | 2021-12-13 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03797924
The ClinicalTrials.gov registry entry for NCT03797924 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Receive ICBN with ropivacaine is the first listed.
NCT03797924 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03797924 about?
NCT03797924 is a clinical study titled "Intercostobrachial Nerve Block (ICBN) for Tourniquet Pain: Is it Necessary?". In this study the investigators would like to show that when patients undergo upper limb surgery under supraclavicular brachial plexus block, additional blocking of the Intercostobrachial Nerve Block (ICBN) does not affect the incidence or course of tourniquet pain.
What is the current status of trial NCT03797924?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 46 participants. The study started on 2019-04-25. Estimated completion is 2021-12-13.
What interventions are being tested in trial NCT03797924?
The interventions under investigation include: Receive ICBN with ropivacaine (DRUG), No ICBN block (BEHAVIORAL).
Who is sponsoring clinical trial NCT03797924?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.